Collection of Blood Samples to Optimise Immunotherapy Methodologies

• Research type

  Research Study

• Full title

  Protocol to Collect Blood Samples from Cancer Patients for use in Optimising Immunotherapy Methodologies

• IRAS ID

  220275

• Contact name

  Marco Purbhoo

• Contact email

  marco.purbhoo@cellmedica.co.uk

• Sponsor organisation

  Cell Medica Ltd.

• Duration of Study in the UK

  5 years, 0 months, 1 days

• Research summary

  Immunotherapy is the treatment of disease by inducing or enhancing, an immune response. Research and testing is required in the development of immunotherapy products.

  In this study, samples (whole blood or apheresis product) will be collected to help in the development of immunotherapies. Specifically, samples collected under this protocol will be used to establish critical quality attributes that will define cell product manufacturing process and ensure robustness and utility in generating cellular immunotherapy products for subjects in future clinical trials.

• REC name

  London - Central Research Ethics Committee

• REC reference

  17/LO/0039

• Date of REC Opinion

  3 Mar 2017

• REC opinion

  Further Information Favourable Opinion